» Articles » PMID: 30006103

Cardiovascular Effects of Radiation Therapy

Overview
Specialty Oncology
Date 2018 Jul 15
PMID 30006103
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation therapy (RT) plays a prominent role in the treatment of many cancers. With increasing use of RT and high overall survival rates, the risks associated with RT must be carefully considered. Of these risks, the cardiovascular and autonomic toxicities have been of significant concern. In fact, cardiovascular disease is the leading cause of nonmalignancy-related death in cancer survivors. The manifestations of radiation induced cardiac injury include the acute toxicities of myopericarditis and late toxicities including constrictive pericarditis, restrictive cardiomyopathy, coronary artery disease, valvular heart disease, heart failure, and conduction abnormalities. Neck and cranial RT have also been associated with significant long-term toxicities including accelerated occlusive carotid artery disease, autonomic dysfunction due to baroreceptor damage, and development of metabolic syndromes due to damage to the hypothalamic-pituitary axis. The clinical manifestations of radiation induced disease may not present until several years following the delivery of radiation. We review the adverse effects of RT on these organ systems and discuss risk reduction strategies that may effectively mitigate some of these adverse outcomes.

Citing Articles

Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: State-of-the-Art Review.

Gent D, Saif M, Dobson R, Wright D JACC CardioOncol. 2024; 6(4):475-495.

PMID: 39239331 PMC: 11372032. DOI: 10.1016/j.jaccao.2024.06.004.


Neighborhood Walkability Is Associated With Lower Burden of Cardiovascular Risk Factors Among Cancer Patients.

Nwana N, Makram O, Nicolas J, Pan A, Gullapelli R, Parekh T JACC CardioOncol. 2024; 6(3):421-435.

PMID: 38983386 PMC: 11229549. DOI: 10.1016/j.jaccao.2024.03.009.


Early Impairment of Paracrine and Phenotypic Features in Resident Cardiac Mesenchymal Stromal Cells after Thoracic Radiotherapy.

Picchio V, Gaetani R, Pagano F, Derevyanchuk Y, Pagliarosi O, Floris E Int J Mol Sci. 2024; 25(5).

PMID: 38474123 PMC: 10932029. DOI: 10.3390/ijms25052873.


ATP protects anti-PD-1/radiation-induced cardiac dysfunction by inhibiting anti-PD-1 exacerbated cardiomyocyte apoptosis, and improving autophagic flux.

Wang J, Zhao J, Meng Z, Guo R, Yang R, Liu C Heliyon. 2023; 9(10):e20660.

PMID: 37842574 PMC: 10570000. DOI: 10.1016/j.heliyon.2023.e20660.


Assessment of short-term effects of thoracic radiotherapy on the cardiovascular parasympathetic and sympathetic nervous systems.

Wu S, Guan W, Zhao H, Li G, Zhou Y, Shi B Front Neurosci. 2023; 17:1256067.

PMID: 37732299 PMC: 10507252. DOI: 10.3389/fnins.2023.1256067.